MyRocky vs DirectMeds (2026): Canada's GLP-1 Telehealth Compared

The Canadian GLP-1 telehealth market has matured quickly. What began as a scramble of general practitioners writing off-label Ozempic prescriptions has evolved into a handful of purpose-built platforms competing on price, clinical depth, and dispensing speed. Two of the most frequently compared are MyRocky and DirectMeds - platforms that share a national ambition but arrive at very different answers about how a GLP-1 program should be structured.

MyRocky is vertically integrated: it operates its own LegitScript-certified pharmacy out of Mississauga, Ontario, and employs a dedicated clinical team that handles intake, prescribing, titration, and follow-up in a single closed loop. DirectMeds is a Canadian online pharmacy that has layered telehealth features onto its dispensing infrastructure - patients can get a consultation and a prescription filled through the same platform, but the pharmacy and clinical functions remain conceptually distinct.

Neither model is inherently superior. The right choice depends on whether you value integrated monitoring and structured dose escalation, or prefer the flexibility and drug-range breadth of an established pharmacy channel. This comparison breaks down both in detail.

Platform Overview

Business Model Differences

The distinction between a telehealth-first company and a pharmacy-first company matters more than it might initially seem. MyRocky built its pharmacy specifically to support its clinical protocols - the dispensing cadence, the medication formulations stocked, and the titration schedule are all designed around one another. When you enroll in MyRocky, you are entering a program, not simply filling a prescription.

DirectMeds arrived at GLP-1 prescriptions through the pharmacy door. It has dispensed Canadian medications for years across a range of categories, and its telehealth capability allows patients to get both the consultation and the fill in one place. That breadth is valuable if you are managing multiple medications or prefer a pharmacy relationship that extends beyond weight management. However, the clinical overlay is thinner - you will interact primarily with pharmacists and contracted practitioners rather than a team whose entire focus is GLP-1 titration.

MyRocky's vertical integration also creates cleaner accountability. If a dose adjustment is warranted, the prescriber, the pharmacist, and the delivery system are all within the same organisation. At DirectMeds, those relationships are more distributed, which can mean slightly more friction around dose changes or clinical queries.

Pricing Breakdown

Cost is often the deciding factor for patients paying entirely out of pocket, and the two platforms structure their fees in ways that make direct comparison non-trivial.

MyRocky's bundled model makes budgeting predictable. For patients who will require ongoing dose escalations and multiple touchpoints with clinical staff - which is essentially everyone on a GLP-1 titration - the all-in structure tends to be more economical over six to twelve months. DirectMeds can be cheaper in the very short term if you already have a prescription and simply need a pharmacy, but add a few follow-up consults and the cost advantage narrows quickly.

Province Coverage

Both platforms serve patients across Canada, though the depth of clinical support available in each province can differ. MyRocky has made a point of being available in all ten provinces, including Quebec - a market that many GLP-1 platforms have historically avoided due to its distinct regulatory environment and French-language requirements.

Clinical Support

MyRocky's 4-week titration check-ins are one of the platform's genuine differentiators. Rather than leaving patients to self-monitor between prescription refills, the clinical team reviews side effects, weight trajectory, and adherence at regular intervals. Dose escalation decisions are made proactively rather than reactively - a meaningful distinction when the standard GLP-1 titration spans 12-20 weeks before reaching a therapeutic maintenance dose.

The in-house clinical team also brings consistency. Patients work with practitioners who specialize in GLP-1 programs rather than rotating generalists. Over time, that continuity allows the clinical team to recognize patterns in how individual patients respond to dose changes, which tends to produce better adherence and fewer dropouts from side effect intolerance.

DirectMeds provides pharmacist-led counselling, which is valuable and often underrated. Pharmacists are the most accessible healthcare professionals in Canada, and a well-run online pharmacy pharmacist can answer most questions about drug interactions, injection technique, and side effect management. Where the model falls short is in physician-level clinical judgment - adjusting doses, ordering labs, or evaluating whether a patient's response is within the expected range requires a prescribing physician, and that interaction is less embedded in the DirectMeds workflow.

Speed to First Dose

In practice, both platforms can get a patient from online intake to first injection within two to five business days, assuming the intake information is complete and no additional lab work is required. MyRocky's integrated model gives it a slight edge in cases where the clinical team identifies a need for a dosing adjustment at intake - there is no third-party pharmacy handoff to slow things down. DirectMeds' pharmacy infrastructure is well-established and its fulfilment operations are reliable, so the gap in routine cases is small.

Where the difference becomes material is in follow-on refills. MyRocky's program structure means refills are anticipated and prepared within the titration schedule. At DirectMeds, refill timing depends on when the patient contacts the platform - a patient who forgets to reorder may face a gap in treatment.

Pros and Cons

Verdict

For the majority of Canadians starting a GLP-1 program from scratch, MyRocky is the stronger choice. The combination of integrated clinical oversight, scheduled titration check-ins, and transparent bundled pricing removes the coordination burden that trips up many patients during the first three to six months of treatment - the period when dose escalation, side effect management, and habit formation all require the most attention.

DirectMeds earns its place for two specific patient profiles. The first is a patient who already has a GLP-1 prescription from a family physician or specialist and simply needs a reliable national pharmacy to fill it - DirectMeds is well-suited to that role. The second is a patient managing multiple medications who values having one pharmacy relationship across all of them, and for whom the GLP-1 clinical overhead is less of a priority because their prescribing physician is already handling it.

If you are self-funding your entire GLP-1 program and want everything coordinated under one roof with predictable monthly costs, start with MyRocky. If you have an existing prescriber and want a trustworthy pharmacy partner, DirectMeds is a reasonable secondary choice.

Sponsored links above. WeightLossInjections.ca may earn a commission if you purchase through these links at no additional cost to you. All editorial opinions are independent. GLP-1 medications require a valid prescription from a licensed Canadian physician.